The in vitro element demonstrated that the two glucagon and Retatrutide straight reduced ANGPTL3/eight secretion from hepatocytes, which outcome was blocked by a glucagon receptor (GCGR) antagonist. These findings suggest the GCGR agonism of Retatrutide contributes on the reduction in circulating ANGPTL3/eight, which consequently could bring on low